Fluorescence anisotropy microplate assay for analysis of steroid receptor-DNA interactions

BioTechniques

Volumn 37, Issue 5, 2004, Pages 807-817

  Wang, Stanley Y ^a   Ahn, Bonnie S ^a   Harris, Rebecca ^a   Nordeen, Steven K ^b   Shapiro, David J ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANISOTROPY; BIOTECHNOLOGY; COMPLEXATION; FLUORESCENCE; GENETIC ENGINEERING; HORMONES;

DIMETHYL SULFOXIDE (DMSO); ESTROGEN RESPONSE ELEMENTS (ERE); FLUORESCENCE ANISOTROPY;

DNA;

DIMETHYL SULFOXIDE; DNA; ESTROGEN RECEPTOR; HORMONE RECEPTOR; PROGESTERONE RECEPTOR; STEROID RECEPTOR; ZINC;

ANALYTIC METHOD; ARTICLE; COMPLEX FORMATION; DNA BINDING; DNA RESPONSIVE ELEMENT; ESTROGEN RESPONSIVE ELEMENT; FLUORESCENCE ANALYSIS; FLUORESCENCE ANISOTROPY MICROPLATE ASSAY; HORMONE RESPONSIVE ELEMENT; PROGESTERONE RESPONSE ELEMENT; RECEPTOR BINDING; SCREENING;

EID: 8444227868     PISSN: 07366205     EISSN: None     Source Type: Journal    
DOI: 10.2144/04375rr01     Document Type: Article

References (33)

1. Jordan, V.C. 2001. The past, present, and future of selective estrogen receptor modulation. Ann. N.Y. Acad. Sci. 949:72-79.
2. Lieberman, R. 2002. Chemoprevention of prostate cancer: current status and future directions. Cancer Metastasis Rev. 21:297-309.
3. Wang, L.H., X.Y. Yang, X. Zhang, K. Mihalic, Y.X. Fan, W. Xiao, O.M. Howard, E Appella, et al. 2004. Suppression of breast cancer by chemical modulation of vulnerable zinc fingers in estrogen receptor. Nat. Med. 10:40-47.
4. Hall, J.M., D.P. McDonnell, and K.S. Korach. 2002. Allosteric regulation of estrogen receptor structure, function, and coactivator recruitment by different estrogen response elements. Mol. Endocrinol. 16:469-486.
5. Klinge, C.M., S.C. Jernigan, S.L. Smith, V.V. Tyulmenkov, and P.C. Kulakosky. 2001. Estrogen response element sequence impacts the conformation and transcriptional activity of estrogen receptor alpha. Mol. Cell. Endocrinol. 174:151-166.
6. Loven, M.A., V.S. Likhite, I. Choi, and A.M. Nardulli. 2001. Estrogen response elements alter coactivator recruitment through allosteric modulation of estrogen receptor beta conformation. J. Biol. Chem. 276:45282-45288.
7. Ramsey, T.L., K.E. Risinger, S.C. Jernigan, K.A. Mattingly, and C.M. Klinge. 2004. Estrogen receptor beta isoforms exhibit differences in ligand-activated transcriptional activity in an estrogen response element sequence-dependent manner. Endocrinology 145:149-160.
8. Schultz, J.R., M.A. Loven, V.M. Melvin, D.P. Edwards, and A.M. Nardulli. 2002. Differential modulation of DNA conformation by estrogen receptors alpha and beta. J. Biol. Chem. 277:8702-8707.
9. Yi, P., M.D. Driscoll, J. Huang, S. Bhagat, R. Hilf, R.A. Bambara, and M. Muyan. 2002. The effects of estrogen-responsive element- and ligand-induced structural changes on the recruitment of cofactors and transcriptional responses by ER alpha and ER beta. Mol. Endocrinol. 16:674-693.
10. Dana, S.L., P.A. Hoener, D.A. Wheeler, C.B. Lawrence, and D.P. McDonnell. 1994. Novel estrogen response elements identified by genetic selection in yeast are differentially responsive to estrogens and antiestrogens in mammalian cells. Mol. Endocrinol. 8:1193-1207.
11. Hyder, S.M., C. Chiappetta, and G.M. Stancel. 1999. Interaction of human estrogen receptors alpha and beta with the same naturally occurring estrogen response elements. Biochem. Pharmacol. 57:597-601.
12. Klinge, C.M. 2001. Estrogen receptor interaction with estrogen response elements. Nucleic Acids Res. 29:2905-2919.
13. Loven, M.A., J.R. Wood, and A.M. Nardulli. 2001. Interaction of estrogen receptors alpha and beta with estrogen response elements. Mol. Cell. Endocrinol. 181:151-163.
14. Nardulli, A.M., L.E. Romine, C. Carpo, G.L. Greene, and B Rainish. 1996. Estrogen receptor affinity and location of consensus and imperfect estrogen response elements influence transcription activation of simplified promoters. Mol. Endocrinol. 10:694-704.
15. Boyer, M., N. Poujol, E. Margeat, and C.A. Royer. 2000. Quantitative characterization of the interaction between purified human estrogen receptor alpha and DNA using fluorescence anisotropy. Nucleic Acids Res. 28:2494-2502.
16. Ozers, M.S., J.J. Hill, K. Ervin, J.R. Wood, A.M. Nardulli, C.A. Royer, and J. Gorski. 1997. Equilibrium binding of estrogen receptor with DNA using fluorescence anisotropy. J. Biol. Chem. 272:30405-30411.
17. Burke, T.J., K.R. Loniello, J.A. Beebe, and K.M. Ervin. 2003. Development and application of fluorescence polarization assays in drug discovery. Comb. Chem. High Throughput Screen. 6:183-194.
18. Owicki, J.C. 2000. Fluorescence polarization and anisotropy in high throughput screening: perspectives and primer. J. Biomol. Screen. 5:297-306.
19. Lin, S., C.L. Bock, D.B. Gardner, J.C. Webster, M.F. Favata, J.M. Trzaskos, and K.R. Oldenburg. 2002. A high-throughput fluorescent polarization assay for nuclear receptor binding utilizing crude receptor extract. Anal. Biochem. 300:15-21.
20. Sportsman, J.R. and L.J. Leytes. 2000. Miniaturization of homogeneous assays using fluorescence polarization. Drug Discov. Today: HTS Supplement. 1:27-32.
21. Sabbah, M., G. Redeuilh, C. Secco, and E.E. Baulieu. 1987. The binding activity of estrogen receptor to DNA and heat shock protein (Mr 90,000) is dependent on receptor-bound metal. J. Biol. Chem. 262:8631-8635.
22. Krieg, A.J., S.A. Krieg, B.S. Ahn, and D.J. Shapiro. 2004. Interplay between estrogen response element sequence and ligands controls in vivo binding of estrogen receptor to regulated genes. J. Biol. Chem. 279:5025-5034.
23. Zhang, C.C., S. Krieg, and D.J. Shapiro. 1999. HMG-1 stimulates estrogen response element binding by estrogen receptor from stably transfected HeLa cells. Mol. Endocrinol. 13:632-643.
24. Melvin, V.S. and D.P. Edwards. 2001. Expression and purification of recombinant human progesterone receptor in baculovirus and bacterial systems, p. 39-54. In B.A. Lieberman (Ed.), Steroid Receptor Methods: Protocols and Assays. Humana Press, Totawa, NJ.
25. Krieg, S.A., A.J. Krieg, and D.J. Shapiro. 2001. A unique downstream estrogen responsive unit mediates estrogen induction of proteinase inhibitor-9, a cellular inhibitor of IL-1beta-converting enzyme (caspase 1). Mol. Endocrinol. 15:1971-1982.
26. Kanamori, H., S. Krieg, C. Mao, V.A. Di Pippo, S. Wang, D.A. Zajchowski, and D.J. Shapiro. 2000. Proteinase inhibitor 9, an inhibitor of granzyme B-mediated apoptosis, is a primary estrogen-inducible gene in human liver cells. J. Biol. Chem. 275:5867-5873.
27. Kuiper, G.G. and J.A. Gustafsson. 1997. The novel estrogen receptor-beta subtype: potential role in the cell- and promoter-specific actions of estrogens and anti-estrogens. FEBS Lett. 410:87-90.
28. Margeat, E., A. Bourdoncle, R. Margueron, N. Poujol, V. Cavailles, and C. Royer. 2003. Ligands differentially modulate the protein interactions of the human estrogen receptors alpha and beta. J. Mol. Biol. 326:77-92.
29. Edwards, D.P. 2000. The role of coactivators and corepressors in the biology and mechanism of action of steroid hormone receptors. Mammary Gland Biol. Neoplasia 5:307-324.
30. Bramlett, K.S., Y. Wu, and T.P. Burris. 2001. Ligands specify coactivator nuclear receptor (NR) box affinity for estrogen receptor subtypes. Mol. Endocrinol. 15:909-922.
31. Rodriguez, A.L., A. Tamrazi, M.L. Collins, and J.A. Katzenellenbogen. 2004. Design, synthesis, and in vitro biological evaluation of small molecule inhibitors of estrogen receptor alpha coactivator binding. J. Med. Chem. 47:600-611.
32. Chen, C.D., D.S. Welsbie, C. Tran, S.H. Baek, R. Chen, R. Vessella, M.G. Rosenfeld, and C.L. Sawyers. 2004. Molecular determinants of resistance to antiandrogen therapy. Nat. Med. 10:33-39.
33. Zhang, J.H., T.D. Chung, and K.R. Oldenburg. 1999. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J. Biomol. Screen. 4:67-73.